|
199
|
554
|
9ljvA |
Structural insights into the polymerase catalyzed fad-capping of hepatitis c viral rna |
|
198
|
554
|
9ljrA |
Structural insights into the polymerase catalyzed fad-capping of hepatitis c viral rna |
|
187
|
554
|
9ljtA |
Structural insights into the polymerase catalyzed fad-capping of hepatitis c viral rna |
|
201
|
554
|
9ljuA |
Structural insights into the polymerase catalyzed fad-capping of hepatitis c viral rna |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
108
|
504
|
9js7A |
Cryoem of antibody complexed with mature zika virus |
|
235
|
926
|
9immA |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
248
|
926
|
9imkA |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
171
|
592
|
9immE |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
180
|
592
|
9imkE |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
17
|
113
|
9immG |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
17
|
113
|
9imkG |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
48
|
187
|
9immB |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
47
|
187
|
9imkB |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
192
|
592
|
9i53A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with atp |
|
196
|
592
|
9i51A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with adp |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
93
|
262
|
9gjzA |
Ntaya methyltransferase (mtase) bound to at-9010 (2'-methyl-2'-fluoro gtp) |
|
74
|
286
|
9fwsB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
71
|
286
|
9fwhB |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
74
|
286
|
9fwmB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00180 |
|
69
|
285
|
9fwpB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00198 |
|
70
|
285
|
9fwrB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
|
71
|
285
|
9fwqB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00218 |
|
71
|
286
|
9fwiB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00025 |
|
72
|
286
|
9fwnB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00219 |
|
71
|
286
|
9fwkB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00123 |
|
69
|
285
|
9fwoB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00216 |
|
74
|
286
|
9fwtB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00259 |
|
69
|
285
|
9fwjB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00079 |
|
70
|
286
|
9fwlB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00167 |
|
74
|
285
|
9fwuB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00421 |
|
30
|
258
|
9eaaA |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
20
|
238
|
9eadB |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
25
|
238
|
9eabB |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
1
|
58
|
9eaaD |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
19
|
230
|
9eacA |
Seneca valley virus empty rotated particle at acidic condition (er-particle[c]) |
|
37
|
268
|
9eaaC |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
0
|
58
|
9eabD |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
24
|
238
|
9eacB |
Seneca valley virus empty rotated particle at acidic condition (er-particle[c]) |
|
24
|
218
|
9eadC |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
16
|
231
|
9eadA |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
31
|
267
|
9eabC |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
23
|
258
|
9eabA |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
